If you reconstitute a vial and see clear solution, either the B12 was omitted or the concentration is extremely low
Analytes (M-CuP or D-CuP) were diluted in PBST buffer (10 mM phosphate-buffered saline, 0.05% Tween-20, pH 7.4) and injected at increasing concentrations at a flow rate of 30 L/min, with 120 s association and 180 s dissociation phases
Latif, R., Realubit, R
The most common side effects reported in trials include mild to moderate gastrointestinal issues: nausea, diarrhea, vomiting, and constipation
If patients develop fever, significant body aches, respiratory symptoms, or other signs consistent with infection while taking tirzepatide, these symptoms should be evaluated as potentially representing an intercurrent illness rather than being attributed solely to the medication
In one of the studies, patients with a mean baseline body mass index (BMI) of 35.3 kg/m and an average HbA1c of 8.3% were randomized to receive varying doses of GLP-3 (ranging from 1 mg to 12 mg) or placebo over a 36-week study period